Bausch Health Companies Inc. Restructuring Reserve, Current
Bausch Health Companies Inc. (BHC) had Restructuring Reserve, Current of $33.00 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2017-08-08
- 2017-06-30: Restructuring Reserve, Current $33.00M.
- 2017-03-31: Restructuring Reserve, Current $22.00M.
- 2016-12-31: Restructuring Reserve, Current $38.00M.
- 2015-12-31: Restructuring Reserve, Current $61.00M; Restructuring Reserve, Current as first filed $60.70M.
| Period end | Restructuring Reserve, Current | Restructuring Reserve, Current as first filed |
|---|---|---|
| 2017-06-30 | $33.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $22.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $38.00M 10-Q · filed 2017-08-08 | |
| 2015-12-31 | $61.00M 10-K · filed 2017-03-01 | $60.70M 10-K · filed 2016-04-29 |
| 2014-12-31 | $66.60M 10-K · filed 2016-04-29 | |
| 2013-12-31 | $112.00M 10-K · filed 2015-02-25 | $111.97M 10-K · filed 2014-02-28 |
| 2012-12-31 | $32.80M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $21.92M 10-K · filed 2013-02-28 | $13.15M 10-K · filed 2012-02-29 |
| 2010-12-31 | $30.14M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |